US biopharming business sets off new GM contamination episode
The biotechnology industry was immersed in a new controversy in November when the first incidents involving contamination of food crops by plants which had been genetically modified to produce pharmaceuticals came to light in the US. The affair has set biotech businesses against food manufacturers and underlined the huge difficulties ahead in safeguarding the food chain as the GM revolution advances.
Sign in to continue
Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access